Hemostats Market - Forecast (2021 - 2026)
According to the Centers for Disease Control and Prevention, around 1,232,339 cesarean delivery occurred in the U.S. annually. A high rate of surgical delivery is accompanied by huge blood loss which necessitates active hemostats such as tools, adhesives, sealants, and others in large quantities to control bleeding. IndustryARC’s analyst reports that North America held a major regional share of 47% during the forecast period of 2019-2025. This huge contribution to the global market is chiefly facilitated by increasing healthcare infrastructures and frequent incidences of disease in this region. With the advancement in medical researches, risk of hemorrhagic deaths, and incessantly growing chronic diseases, several hemostats active catalytic hemostatic agents have been introduced into the forefront market such as thrombin, oxidized regenerated cellulose, gelatin, collagen, and many others. The usage of hemostatic agents has gradually paved its way into several medical procedures such as tissue reconstruction, vascular procedure, retracting view and others, as a result, there is a significant hike in hemostat market demand. Consequently, global hemostat market leveraged huge revenue income worth $6.7 billion as of 2018 and the CAGR is estimated to increase at 7.29% during the forecast period of 2019-2025.
Hemostats Market Growth Drivers:
Growing public awareness about minimally invasive surgical procedures is boosting the use of certain hemostatic sealants and adhesives which are contributing factors to the global hemostats market revenue income.
Rise in chronic diseases, fatal injuries, cesarean deliveries, and major organ surgeries significantly drive the hemostats market demand across the world.
Increasing R&D activities initiated by the government and private organizations for producing effective hemostatic agents coupled with advanced technological innovations in the healthcare industry will effectively induce huge market benefits over the future years.
Hemostats Market Key Players:
The pioneering companies in the global hemostats market includes Johnson and Johnson, Pfizer Inc., C. R. Bard, Inc., CSL Behring, Baxter International Inc., Mallinckrodt Pharmaceuticals, Medtronic plc., Vascular Solutions, Inc., Stryker Corporation, B. Braun Melsungen AG., and others.
Hemostats Market Trends:
BoneSeal Hemostats During Sternotomy:
Recently two leading companies, Terumo Cardiovascular Group and Hemostasis, announced a new hemostatic solution -BoneSeal®- into the United States market. This revolutionary product will act as an inhibitor of excessive blood loss during sternotomy procedures due to bone cuts or damage. Not only will the BoneSeal minimize bleeding, but it will also aid post-surgical healing and promote bone growth. A combination of synthetic polymers and biocompatible materials, BoneSeal is a vital solution in the cardiac surgery market.
Hemostats Market Research Scope:
The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Hemostats market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of Hemostats in Hemostats market, and their specific applications in different areas.
Request Sample
Risk of cardiovascular diseases is increasing rapidly across the globe which majorly involves cardiac surgery. According to statistical data published by the American College of Cardiology in 2017, cardiovascular disease, singularly, leads to 31% of global deaths. This statistic is indicative of the propelling scope of the hemostats market demand attributed to the associated number of surgical procedures incorporated to treat CVD throughout the world. Consequently, the demand for cardiac surgery will generate huge revenue prospects for the hemostats market, which is projected to grow at a CAGR of 7.9% through to 2025.
Risk of cardiovascular diseases is increasing rapidly across the globe which majorly involves cardiac surgery. According to statistical data published by the American College of Cardiology in 2017, cardiovascular disease, singularly, leads to 31% of global deaths. This statistic is indicative of the propelling scope of the hemostats market demand attributed to the associated number of surgical procedures incorporated to treat CVD throughout the world. Consequently, the demand for cardiac surgery will generate huge revenue prospects for the hemostats market, which is projected to grow at a CAGR of 7.9% through to 2025.
Hemostats Market Growth Drivers:
Growing public awareness about minimally invasive surgical procedures is boosting the use of certain hemostatic sealants and adhesives which are contributing factors to the global hemostats market revenue income.
Rise in chronic diseases, fatal injuries, cesarean deliveries, and major organ surgeries significantly drive the hemostats market demand across the world.
Increasing R&D activities initiated by the government and private organizations for producing effective hemostatic agents coupled with advanced technological innovations in the healthcare industry will effectively induce huge market benefits over the future years.
Hemostats Market Key Players:
The pioneering companies in the global hemostats market includes Johnson and Johnson, Pfizer Inc., C. R. Bard, Inc., CSL Behring, Baxter International Inc., Mallinckrodt Pharmaceuticals, Medtronic plc., Vascular Solutions, Inc., Stryker Corporation, B. Braun Melsungen AG., and others.
Inquiry Before Buying
Johnson and Johnson is one of the leading pharmaceutical and medical devices manufacturing company which actively delivers various hemostatic agents to the end-users across the world. Surgical® Absorbable Hemostat is one of its contribution to the medical industries which readily stops bleeding thereby speeding the healing of surgical and traumatic wounds.
Johnson and Johnson is one of the leading pharmaceutical and medical devices manufacturing company which actively delivers various hemostatic agents to the end-users across the world. Surgical® Absorbable Hemostat is one of its contribution to the medical industries which readily stops bleeding thereby speeding the healing of surgical and traumatic wounds.
Hemostats Market Trends:
BoneSeal Hemostats During Sternotomy:
Recently two leading companies, Terumo Cardiovascular Group and Hemostasis, announced a new hemostatic solution -BoneSeal®- into the United States market. This revolutionary product will act as an inhibitor of excessive blood loss during sternotomy procedures due to bone cuts or damage. Not only will the BoneSeal minimize bleeding, but it will also aid post-surgical healing and promote bone growth. A combination of synthetic polymers and biocompatible materials, BoneSeal is a vital solution in the cardiac surgery market.
Hemostats Market Research Scope:
The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Hemostats market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of Hemostats in Hemostats market, and their specific applications in different areas.
We also publish more than 100 reports every month in "Lifesciences and Healthcare", Go through the Domain if there are any other areas for which you would like to get a market research study.
Comments
Post a Comment